Takeda to buy out Abbott in U.S. joint venture, source says

03/19/2008 | Bloomberg1 · Reuters

Japanese drugmaker Takeda Pharmaceutical Co. Ltd. is reportedly trying to buy Abbott Laboratories' 50% stake in their U.S. venture for $5 billion. The companies declined to comment on the rumored buyout, which would have Takeda taking over TAP Pharmaceutical Products, but with Abbott getting the venture's prostate cancer division and the rights to some of Takeda's drug candidates.

View Full Article in:

Bloomberg1 · Reuters

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Product Development Manager, Disposable Medical Products
ASAHI INTECC, Orange County CA R&D Center
Santa Ana, CA
Neurovascular Intervention Product Sales Rep, North East
Multiple Locations, SL_Multiple Locations
Vice President of Regulatory Affairs
Pentec Health
Boothwyn, PA
Sr Coordinator Clinical Research (US/TA/00/0073/SL) - 1400000AQX
Santa Clara, CA
Senior Director, Biostatistics
Edwards Lifesciences
Irvine, CA